Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heartbeam, Inc. - Common Stock (NQ: BEAT )

2.350 +0.050 (+2.17%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Heartbeam, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Present at JP Morgan 2025 Annual Healthcare Conference
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference
From HeartBeam, Inc.
Via Business Wire
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures FDA Clearance for Innovative Arrhythmia Assessment Device
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Presents Positive Data for Groundbreaking Technology at AHA Conference
Via Investor Brand Network
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Technology with FDA Submissions and Key Leadership Appointments
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
HeartBeam Reports Third Quarter 2024 Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q3 Earnings Call with Key Regulatory and Initiative Updates
Via Investor Brand Network
Topics Earnings Intellectual Property
Exposures Financial Intellectual Property
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards
From HeartBeam, Inc.
Via Business Wire
Lifesaving Portable, AI Augmented Cardiac Monitoring Technology Poised for Commercial Launch Under New Industry Leader CEO: Heartbeam, Inc. (NASDAQ: BEAT)
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
TechMediaBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Robert Eno as New CEO to Lead Next Phase of Growth and Innovation
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property Product Safety
HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Industry Expert, Pioneer as New Chief AI Scientist
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Industry Expert as New CFO
Via Investor Brand Network
Topics Intellectual Property Retirement
Exposures Intellectual Property Pension
HeartBeam Names Timothy Cruickshank as Chief Financial Officer
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2024 Financial Report, Operational Update
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
BEAT Stock Earnings: HeartBeam Misses EPS for Q2 2024
BEAT stock results show that HeartBeam missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
HeartBeam Reports Second Quarter 2024 Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Conference Call, Webcast to Discuss Q2 Results
Via Investor Brand Network
HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Now Listed on Russell Microcap Index
Via Investor Brand Network
HeartBeam Added to Russell Microcap® Index
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Positive Study Data for Its AI Program
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc.’s (NASDAQ: BEAT) AIMIGo(TM) Recognized as ‘Best New ECG Technology Solution’ in Awards Program
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program
From HeartBeam, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.